K173837 is an FDA 510(k) clearance for the RHYTHMIA HDx Mapping System (with software Version 2.0). This device is classified as a Computer, Diagnostic, Programmable (Class II - Special Controls, product code DQK).
Submitted by Boston Scientific Corporation (Cambridge, US). The FDA issued a Cleared decision on July 25, 2018, 219 days after receiving the submission on December 18, 2017.
This device falls under the Cardiovascular FDA review panel. Regulated under 21 CFR 870.1425.
| 510(k) Number | K173837 FDA.gov |
| FDA Decision | Cleared Substantially Equivalent - Traditional 510(k) (SESE) |
| Date Received | December 18, 2017 |
| Decision Date | July 25, 2018 |
| Days to Decision | 219 days |
| Submission Type | Traditional |
| Review Panel | Cardiovascular (CV) |
| Summary | Summary PDF |
| Product Code | DQK — Computer, Diagnostic, Programmable |
| Device Class | Class II - Special Controls |
| CFR Regulation | 21 CFR 870.1425 |